/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

I

Ilaria Massa

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

103

Papers

957

Citations

17

h-index

27

i10-index

Ilaria Massa is an academic researcher from Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori. The author has contributed to research in topics: Health Systems, Economic Evaluations, Quality of Life & Breast Cancer Treatment Studies & Lung Cancer Treatments and Mutations. The author has an h-index of 17, co-authored 88 publications.

ORCID: 0000-0003-1388-3175

Research Topics

Health Systems, Economic Evaluations, Quality of Life Breast Cancer Treatment Studies Lung Cancer Treatments and Mutations Economic and Financial Impacts of Cancer Palliative Care and End-of-Life Issues

Papers by this author

works

Uncovering the genomic heterogeneity of multifocal breast cancer

2015 · The Journal of Pathology · 82 citations

https://doi.org/10.1002/path.4540

Christine Desmedt Debora Fumagalli Elisabetta Pietri Gabriele Zoppoli

Chronological age or biological age: What drives the choice of adjuvant treatment in elderly breast cancer patients?

2021 · Translational Oncology · 35 citations

https://doi.org/10.1016/j.tranon.2021.101300

Roberta Maltoni Sara Ravaioli Giuseppe Bronte Massimiliano Mazza

Role of Androgen and Estrogen Receptors as Prognostic and Potential Predictive Markers of Ductal Carcinoma in Situ of the Breast

2015 · The International Journal of Biological Markers · 15 citations

https://doi.org/10.5301/jbm.5000163

Maria Maddalena Tumedei Rosella Silvestrini Sara Ravaioli Ilaria Massa

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

2006 · BMC Cancer · 13 citations

https://doi.org/10.1186/1471-2407-6-76

Alessandro Passardi Ilaria Massa Wainer Zoli Lorenzo Gianni

The challenge of sustainability in healthcare systems: economic and organizational impact of subcutaneous formulations for rituximab and trastuzumab in onco-hematology

2020 · Expert Review of Pharmacoeconomics & Outcomes Research · 13 citations

https://doi.org/10.1080/14737167.2020.1764353

Mattia Altini Nicola Gentili William Balzi Gerardo Musuraca

PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial

2020 · Trials · 9 citations

https://doi.org/10.1186/s13063-020-04527-4

Oriana Nanni Pierluigi Viale Bernadette Vertogen Claudia Lilli

Research topics

topics

Health Systems, Economic Evaluations, Quality of Life

Breast Cancer Treatment Studies

Lung Cancer Treatments and Mutations

Economic and Financial Impacts of Cancer

Palliative Care and End-of-Life Issues

Chat about Author

Papers

Chat

Click to start Chat